Erste Asset Management Gmb H Jounce Therapeutics, Inc. Transaction History

Erste Asset Management Gmb H

$8.35 Trillion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 26, 2024	SELL	N/A	-1,459,587 Closed	0 $0
Q2 2023 Nov 26, 2024	SELL	$0.0 - $1.94 $0 - $3.03 Million	-1,559,587 Closed	0 $0
Q1 2023 Nov 26, 2024	BUY	$0.9 - $1.85 $639,000 - $1.31 Million	710,000 Added 83.57%	1,559,587 $2.89 Billion
Q4 2022 Nov 26, 2024	BUY	$0.64 - $1.99 $390,400 - $1.21 Million	610,000 Added 71.8%	1,459,587 $1.62 Billion
Q3 2022 Nov 26, 2024	BUY	$2.73 - $4.92 $2.32 Million - $4.18 Million	849,587 New	849,587 $1.98 Billion
Q2 2022 Nov 26, 2024	BUY	$2.8 - $7.67 $1.51 Million - $4.14 Million	539,487 Added 173.97%	849,587 $2.57 Billion
Q1 2022 Nov 22, 2024	SELL	$6.01 - $8.54 $60,100 - $85,399	-10,000 Reduced 1.28%	769,587 $5.23 Billion
Q4 2021 Nov 22, 2024	BUY	$7.11 - $9.64 $5.19 Million - $7.03 Million	729,587 New	729,587 $5.92 Billion
Q3 2021 Nov 22, 2024	BUY	$5.04 - $8.73 $604,800 - $1.05 Million	120,000 Added 18.19%	779,587 $5.79 Billion
Q2 2021 Nov 22, 2024	BUY	$6.58 - $10.66 $164,500 - $266,500	25,000 Added 3.94%	659,587 $4.47 Billion
Q1 2021 Nov 22, 2024	BUY	$6.73 - $13.87 $336,500 - $693,500	50,000 Added 8.55%	634,587 $6.49 Billion
Q3 2020 Nov 22, 2024	BUY	$4.58 - $10.95 $2.68 Million - $6.4 Million	584,587 New	584,587 $4.77 Billion
Q2 2020 Nov 22, 2024	SELL	$4.17 - $7.58 $208,500 - $379,000	-50,000 Reduced 8.27%	554,587 $3.83 Billion
Q1 2020 Nov 22, 2024	SELL	$2.91 - $8.7 $198,171 - $592,470	-68,100 Reduced 10.12%	604,587 $2.87 Billion
Q4 2019 Nov 22, 2024	BUY	$2.81 - $9.21 $1.89 Million - $6.2 Million	672,687 New	672,687 $5.47 Billion
Q3 2019 Nov 22, 2024	BUY	$3.33 - $4.93 $83,250 - $123,250	25,000 Added 4.11%	632,687 $2.11 Billion
Q2 2019 Nov 22, 2024	BUY	$4.3 - $6.73 $167,700 - $262,470	39,000 Added 6.86%	607,687 $3 Billion
Q1 2019 Nov 22, 2024	BUY	$3.43 - $6.87 $1.95 Million - $3.91 Million	568,687 New	568,687 $3.52 Billion
Q4 2018 Nov 26, 2024	BUY	$2.69 - $6.71 $834,169 - $2.08 Million	310,100 New	310,100 $1.04 Billion

Others Institutions Holding JNCE

# of Institutions

Shares Held

720K

Call Options Held

Put Options Held

View Full List

About Jounce Therapeutics, Inc.

Ticker JNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,694,200
Description
Jounce Therapeutics, Inc., a clinical-stage immunotherapy company, develops therapies for the treatment of cancer. The company develops vopratelimab, a clinical-stage monoclonal antibody, which is in Phase II clinical trial that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of T cells found in various solid ...

More about JNCE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Erste Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Erste Asset Management Gmb H with notifications on news.

Account